Canaccord analyst Whitney Ijem reiterated a Buy rating and $38.00 price target on Pharming Group (NASDAQ: PHAR).The analyst commented: 'Overnight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE